Level 1: | Quoted (unadjusted) prices |
in active markets for identical | |
assets or liabilities. | |
Level 2: | Other techniques for which all |
inputs which have a significant | |
effect on the recorded fair | |
value are observable, either | |
directly or indirectly. | |
Level 3: | Techniques which use inputs |
which have a significant effect | |
on the recorded fair value that | |
are not based on observable | |
market data. |
| 2024 | 2023 | 2022 | ||||
$1 equivalent | Average | Closing | Average | Closing | Average | Closing |
Sterling | £0.78 | £0.80 | £0.80 | £0.78 | £0.81 | £0.83 |
Euro | €0.92 | €0.96 | €0.92 | €0.90 | €0.95 | €0.94 |
2024 | 2023 | 2022 | |
Year ended 31 December | $m | $m | $m |
Americas | 1,141 | 1,105 | 1,005 |
EMEAA | 748 | 677 | 552 |
Greater China | 161 | 161 | 87 |
Central | 262 | 221 | 199 |
Revenue from reportable segments | 2,312 | 2,164 | 1,843 |
System Fund and reimbursable revenues | 2,611 | 2,460 | 2,049 |
Total revenue | 4,923 | 4,624 | 3,892 |
2024 | 2023 | 2022 | |
Year ended 31 December | $m | $m | $m |
Americas | 828 | 815 | 761 |
EMEAA | 270 | 215 | 152 |
Greater China | 98 | 96 | 23 |
Central | (72) | (107) | (108) |
Operating profit from reportable segments | 1,124 | 1,019 | 828 |
System Fund and reimbursable result | (83) | 19 | (105) |
Operating exceptional items (note 6) | – | 28 | (95) |
Operating profit | 1,041 | 1,066 | 628 |
Net financial expenses | (140) | (52) | (96) |
Fair value (losses)/gains on contingent purchase consideration | (4) | (4) | 8 |
Profit be fore tax | 897 | 1,010 | 540 |
Tax | (269) | (260) | (164) |
Profit for the year | 628 | 750 | 376 |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2024 | $m | $m | $m | $m | $m |
Depreciation and amortisation a | 24 | 12 | 3 | 26 | 65 |
Contract assets deduction in revenue | 24 | 18 | 1 | – | 43 |
Equity-settled share-based payments cost | 10 | 5 | 3 | 19 | 37 |
Share of pro fit o f associates and joint ventures | (4) | (6) | – | – | (10) |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2023 | $m | $m | $m | $m | $m |
Depreciation and amortisation a | 24 | 12 | 4 | 27 | 67 |
Contract assets deduction in revenue | 21 | 15 | 1 | – | 37 |
Equity-settled share-based payments cost | 9 | 4 | 2 | 16 | 31 |
Share of pro fit o f associates and joint ventures | |||||
(excluding exceptional items) | (5) | (8) | – | – | (13) |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2022 | $m | $m | $m | $m | $m |
Depreciation and amortisation a | 23 | 13 | 4 | 28 | 68 |
Contract assets deduction in revenue | 18 | 13 | 1 | – | 32 |
Equity-settled share-based payments cost | 8 | 4 | 2 | 14 | 28 |
Share of pro fit o f associates | |||||
(excluding exceptional items) | (1) | – | – | – | (1) |
2024 | 2023 | 2022 | |
Year ended 31 December | $m | $m | $m |
Revenue | |||
United Kingdom | 291 | 263 | 243 |
United States | 1,902 | 1,777 | 1,659 |
Rest of World | 1,119 | 1,020 | 773 |
3,312 | 3,060 | 2,675 | |
System Fund revenues (note 31) | 1,611 | 1,564 | 1,217 |
4,923 | 4,624 | 3,892 |
2024 | 2023 | |
31 December | $m | $m |
Non-current assets | ||
United Kingdom | 104 | 100 |
United States | 1,370 | 1,332 |
Rest of World | 778 | 660 |
2,252 | 2,092 |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2024 | $m | $m | $m | $m | $m |
Franchise and base management fees | 958 | 277 | 122 | – | 1,357 |
Incentive management fees | 21 | 118 | 39 | – | 178 |
Central revenue | – | – | – | 239 | 239 |
Revenue from fee business | 979 | 395 | 161 | 239 | 1,774 |
Revenue from owned, leased and managed lease hotels | 162 | 353 | – | – | 515 |
Revenue from insurance activities | – | – | – | 23 | 23 |
1,141 | 748 | 161 | 262 | 2,312 | |
System Fund revenues (note 31) | 1,611 | ||||
Reimbursable revenues (note 31) | 1,000 | ||||
Total revenue | 4,923 |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2023 | $m | $m | $m | $m | $m |
Franchise and base management fees | 936 | 253 | 115 | – | 1,304 |
Incentive management fees | 21 | 101 | 46 | – | 168 |
Central revenue | – | – | – | 200 | 200 |
Revenue from fee business | 957 | 354 | 161 | 200 | 1,672 |
Revenue from owned, leased and managed lease hotels | 148 | 323 | – | – | 471 |
Revenue from insurance activities | – | – | – | 21 | 21 |
1,105 | 677 | 161 | 221 | 2,164 | |
System Fund revenues (note 31) | 1,564 | ||||
Reimbursable revenues (note 31) | 896 | ||||
Total revenue | 4,624 |
Greater | |||||
Americas | EMEAA | China | Central | Group | |
Year ended 31 December 2022 | $m | $m | $m | $m | $m |
Franchise and base management fees | 861 | 215 | 71 | – | 1,147 |
Incentive management fees | 18 | 69 | 16 | – | 103 |
Central revenue | – | – | – | 184 | 184 |
Revenue from fee business | 879 | 284 | 87 | 184 | 1,434 |
Revenue from owned, leased and managed lease hotels | 126 | 268 | – | – | 394 |
Revenue from insurance activities | – | – | – | 15 | 15 |
1,005 | 552 | 87 | 199 | 1,843 | |
System Fund revenues (note 31) | 1,217 | ||||
Reimbursable revenues (note 31) | 832 | ||||
Total revenue | 3,892 |
2024 | 2023 | |
31 December | $m | $m |
Trade receivables (note 16) | 651 | 580 |
Contract assets | 650 | 459 |
Deferred revenue | (2,060) | (1,848) |
2024 | 2023 | |
$m | $m | |
At 1 January | 459 | 367 |
Additions | 237 | 129 |
Recognised as a deduction to revenue | (43) | (37) |
Impairment reversals (note 6) | 3 | – |
Repayments | – | (7) |
Exchange and other adjustments | (6) | 7 |
At 31 December | 650 | 459 |
Analysed as: | ||
Current | 38 | 35 |
Non-current | 612 | 424 |
650 | 459 |
Loyalty | Other | Application & | |||
programme | co-brand fees | re-licensing fees | Other | Total | |
$m | $m | $m | $m | $m | |
At 1 January 2023 | 1,411 | 33 | 167 | 113 | 1,724 |
Increase in deferred revenue | 672 | – | 27 | 63 | 762 |
Recognised as revenue | (554) | (11) | (23) | (48) | (636) |
Exchange and other adjustments | – | – | – | (2) | (2) |
At 31 December 2023 | 1,529 | 22 | 171 | 126 | 1,848 |
Increase in deferred revenue | 726 | 97 | 23 | 61 | 907 |
Recognised as revenue | (602) | (8) | (23) | (58) | (691) |
Exchange and other adjustments | – | – | – | (4) | (4) |
At 31 December 2024 | 1,653 | 111 | 171 | 125 | 2,060 |
Analysed as: | |||||
Current | 661 | 12 | 23 | 70 | 766 |
Non-current | 992 | 99 | 148 | 55 | 1,294 |
1,653 | 111 | 171 | 125 | 2,060 | |
At 31 December 2023 analysed as: | |||||
Current | 649 | 11 | 22 | 70 | 752 |
Non-current | 880 | 11 | 149 | 56 | 1,096 |
1,529 | 22 | 171 | 126 | 1,848 |
| 2024 | 2023 | |||||
Loyalty and | Loyalty and | |||||
co-brand | Other | Total | co-brand | Other | Total | |
$m | $m | $m | $m | $m | $m | |
Less than one year | 673 | 93 | 766 | 660 | 92 | 752 |
Between one and two years | 355 | 43 | 398 | 346 | 43 | 389 |
Between two and three years | 214 | 30 | 244 | 195 | 32 | 227 |
Between three and four years | 140 | 24 | 164 | 118 | 24 | 142 |
Between four and five years | 95 | 22 | 117 | 73 | 20 | 93 |
More than five years | 287 | 84 | 371 | 159 | 86 | 245 |
1,764 | 296 | 2,060 | 1,551 | 297 | 1,848 | |
2024 | 2023 | |
$m | $m | |
At 1 January | 87 | 80 |
Costs incurred | 18 | 15 |
Charged to income statement | (8) | (8) |
Exchange and other adjustments | (2) | – |
At 31 December | 95 | 87 |
Analysed as: | ||
Current | 5 | 5 |
Non-current | 90 | 82 |
95 | 87 |
2024 | 2023 a | 2022 a | |
Staff costs | $m | $m | $m |
Wages and salaries | 1,890 | 1,752 | 1,558 |
Social security costs | 159 | 143 | 117 |
Share-based payment costs (note 27) | 67 | 56 | 46 |
Pension and other post-retirement benefits: | |||
Defined benefit plans | 7 | 4 | 2 |
Defined contribution plans | 62 | 58 | 53 |
2,185 | 2,013 | 1,776 | |
Analysed as: | |||
Costs borne by IHG b | 800 | 747 | 646 |
Costs borne by the System Fund or reimbursed | 1,385 | 1,266 | 1,130 |
2,185 | 2,013 | 1,776 |
Monthly average number of employees, including part-time employees | 2024 | 2023 | 2022 |
Employees whose costs are borne by IHG: | |||
Americas | 1,612 | 1,578 | 1,548 |
EMEAA | 3,635 | 3,642 | 3,638 |
Greater China | 357 | 352 | 333 |
Central | 1,783 | 1,720 | 1,528 |
7,387 | 7,292 | 7,047 | |
Employees whose costs are borne by the System Fund or are reimbursed | 20,752 | 20,306 | 18,833 |
28,139 | 27,598 | 25,880 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Base salaries, fees, annual performance payments and bene fits | 6.9 | 6.9 | 7.9 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Audit of the Financial Statements | 7 | 7 | 6 |
Audit of subsidiaries | 3 | 3 | 2 |
Other assurance services a | 1 | 1 | 1 |
11 | 11 | 9 | |
Under SEC regulations analysed as: | |||
Audit | 10 | 10 | 8 |
Other audit-related | 1 | 1 | 1 |
11 | 11 | 9 |
2024 | 2023 | 2022 | ||
Note | $m | $m | $m | |
Administrative expenses: | ||||
Costs of ceasing operations in Russia | (a) | – | – | (12) |
Commercial litigation and disputes | (b) | (12) | – | (28) |
(12) | – | (40) | ||
Share of pro fits/(losses) o f associate | (c) | – | 18 | (60) |
Other operating income | (d) | – | 10 | – |
Impairment reversal on financial assets | (e) | 6 | – | – |
Other net impairment reversals/(charges): | ||||
Management agreements – reversal | 11 | – | – | 12 |
Property, plant and equipment – charge | 12 | – | – | (10) |
| – reversal | 12 | 3 | – | 3 |
Right-of-use assets – charge | 12 | – | – | (2) |
| – reversal | 13 | – | – | 2 |
Associates – reversal | 14 | – | – | 2 |
Contract assets – charge | (f) | – | – | (5) |
| – reversal | (f) | 3 | – | 3 |
6 | – | 5 | ||
Operating exceptional items | – | 28 | (95) | |
Tax on exceptional items | (g) | – | (7) | 26 |
Tax | – | (7) | 26 | |
Operating exceptional items analysed as: | ||||
Americas | 4 | 27 | (46) | |
EMEAA | (4) | 1 | (49) | |
– | 28 | (95) |
2024 | 2023 | 2022 | ||||
Current | Deferred | Current | Deferred | Current | Deferred | |
tax | tax | tax | tax | tax | tax | |
$m | $m | $m | $m | $m | $m | |
Costs of ceasing operations in Russia | – | – | – | – | 3 | – |
Commercial litigation and disputes | – | 2 | – | – | 8 | (2) |
Share of (pro fits)/losses o f associate | – | – | – | (4) | 15 | – |
Other operating income | – | – | (3) | – | – | – |
Impairment reversal on financial assets | – | (1) | – | – | – | – |
Other net impairment (reversals)/charges | – | (1) | – | – | 1 | (5) |
Adjustments in respect of prior years a | – | – | – | – | 6 | – |
– | – | (3) | (4) | 33 | (7) | |
Total current and deferred tax | – | (7) | 26 | |||
2024 | 2023 | 2022 | |
$m | $m | $m | |
Financial income | |||
Financial income on deposits and money market funds | 48 | 33 | 17 |
Interest income on loans and other assets | 15 | 6 | 5 |
63 | 39 | 22 | |
Financial expenses | |||
Interest expense on external borrowings | 131 | 85 | 92 |
Interest expense on lease liabilities | 30 | 29 | 29 |
Unwind of discount on deferred purchase consideration | – | 1 | – |
Foreign exchange losses/(gains) | 25 | (35) | (10) |
Other charges | 17 | 11 | 7 |
203 | 91 | 118 |
United Kingdom | Other jurisdictions | Total | |||||||
2024 | 2023 | 2022 | 2024 | 2023 | 2022 | 2024 | 2023 | 2022 | |
$m | $m | $m | $m | $m | $m | $m | $m | $m | |
Current tax | |||||||||
Current period a | 24 | 16 | 6 | 292 | 245 | 177 | 316 | 261 | 183 |
Adjustments in respect of prior periods | – | – | (2) | – | 12 | (5) | – | 12 | (7) |
24 | 16 | 4 | 292 | 257 | 172 | 316 | 273 | 176 | |
Deferred tax | |||||||||
Origination and reversal of temporary | |||||||||
differences | 11 | 1 | (1) | (56) | (21) | (6) | (45) | (20) | (7) |
Changes in tax rates and tax laws | – | – | – | – | 2 | – | – | 2 | – |
Adjustments to unprovided or | |||||||||
unrecognised deferred tax b | – | – | (2) | – | 5 | – | – | 5 | (2) |
Adjustments in respect of prior periods | (2) | 1 | 2 | – | (1) | (5) | (2) | – | (3) |
9 | 2 | (1) | (56) | (15) | (11) | (47) | (13) | (12) | |
Income tax charge for the year c | 33 | 18 | 3 | 236 | 242 | 161 | 269 | 260 | 164 |
2024 | 2023 | 2022 | |
% | % | % | |
Tax at UK blended rate | 25.0 | 23.5 | 19.0 |
Tax credits | (0.6) | (0.5) | (0.1) |
System Fund a | 1.2 | (1.3) | 3.1 |
Foreign exchange losses/(gains) | 1.0 | (1.0) | (0.9) |
Other permanent differences b | (0.5) | 0.9 | 0.5 |
Non-recoverable foreign taxes | 2.4 | 1.3 | 3.5 |
Net effect of different rates of tax c | 1.5 | 1.5 | 6.3 |
Effects of substantive enactment of UAE tax rates and laws d | – | (0.9) | – |
Effect of changes in other tax rates and laws | – | 0.2 | 0.1 |
Items on which deferred tax arose but where no deferred tax is recognised e | 0.2 | 0.2 | 1.2 |
Effect of adjustments to unprovided or unrecognised deferred taxes f | – | 0.5 | (0.4) |
Adjustment to tax charge in respect of prior periods g | (0.2) | 1.3 | (1.9) |
30.0 | 25.7 | 30.4 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
China a | 11 | 5 | 10 |
Singapore a | 7 | 4 | 1 |
United Kingdom | 10 | 8 | 3 |
United States | 220 | 171 | 165 |
Other jurisdictions | 23 | 18 | 10 |
271 | 206 | 189 | |
Taxes withheld at source | 38 | 37 | 22 |
Tax paid per cash flow | 309 | 243 | 211 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Current tax charge in the Group income statement | 316 | 273 | 176 |
Current tax credit in the Group statement of comprehensive income | (3) | (6) | (2) |
Current tax credit taken directly to equity | (6) | (5) | – |
Total current tax charge | 307 | 262 | 174 |
Movements to tax contingencies a | (4) | (2) | 10 |
Timing differences of cash tax paid and foreign exchange differences | 6 | (17) | 27 |
Tax paid per cash flow | 309 | 243 | 211 |
Property, | Deferred | Intangible | Other | ||||||||
plant, | Deferred | compensation | assets | short-term | |||||||
equipment | Application | gains on | and employee | Deferred | Research and | excluding | temporary | ||||
and software | fees | loan notes c | Associates | Losses d | benefits a | revenue a,b | development a | software | differences a,e | Total | |
$m | $m | $m | $m | $m | $m | $m | $m | $m | $m | $m | |
At 1 January 2023 | (53) | 41 | (34) | (59) | 79 | 84 | – | 8 | (40) | 22 | 48 |
Group income statement | 22 | 1 | – | (1) | – | 4 | – | 7 | (9) | (11) | 13 |
Group statement | |||||||||||
of comprehensive | |||||||||||
income | – | – | – | – | (6) | – | – | – | – | (5) | (11) |
Group statement | |||||||||||
of changes in equity | – | – | – | – | – | 6 | – | – | – | – | 6 |
Exchange and | |||||||||||
other adjustments | 1 | – | – | – | 3 | 1 | – | – | 3 | 2 | 10 |
At 31 December 2023 | (30) | 42 | (34) | (60) | 76 | 95 | – | 15 | (46) | 8 | 66 |
Group income statement | 21 | – | – | 1 | (7) | 9 | 30 | 18 | (14) | (11) | 47 |
Group statement | |||||||||||
of comprehensive | |||||||||||
income | – | – | – | – | (3) | – | – | – | – | (13) | (16) |
Group statement | |||||||||||
of changes in equity | – | – | – | – | – | 9 | – | – | – | – | 9 |
Exchange and | |||||||||||
other adjustments | – | – | – | – | (1) | – | – | – | – | (1) | (2) |
At 31 December 2024 | (9) | 42 | (34) | (59) | 65 | 113 | 30 | 33 | (60) | (17) | 104 |
2024 | 2023 | |
$m | $m | |
Deferred tax assets | 122 | 134 |
Deferred tax liabilities | (18) | (68) |
104 | 66 | |
Analysed as: | ||
United Arab Emirates | 12 | 9 |
United Kingdom | 99 | 113 |
United States | – | (53) |
Other | (7) | (3) |
104 | 66 |
| Gross | Unrecognised deferred tax | |||
2024 | 2023 | 2024 | 2023 | |
$m | $m | $m | $m | |
Revenue losses | 432 | 450 | 75 | 79 |
Capital losses | 580 | 580 | 146 | 146 |
1,012 | 1,030 | 221 | 225 | |
Tax credits | 46 | 32 | 46 | 32 |
Other a | 22 | 16 | 7 | 5 |
1,080 | 1,078 | 274 | 262 | |
| Gross | Unrecognised deferred tax | |||
2024 | 2023 | 2024 | 2023 | |
Expiry date | $m | $m | $m | $m |
2024 | – | 6 | – | 1 |
2025 | 11 | 11 | 2 | 2 |
2026 | 7 | 7 | 1 | 1 |
2027 | 7 | 7 | 1 | 1 |
2028 | – | 6 | – | 1 |
2029 | 10 | 10 | 10 | 10 |
After 2031 | 36 | 22 | 36 | 22 |
| 2024 | 2023 | 2022 | ||||
cents | cents | cents | ||||
Paid during the year | per share | $m | per share | $m | per share | $m |
Final (declared for previous year) | 104.0 | 172 | 94.5 | 166 | 85.9 | 154 |
Interim | 53.2 | 87 | 48.3 | 79 | 43.9 | 79 |
157.2 | 259 | 142.8 | 245 | 129.8 | 233 | |
Basic earnings per ordinary share | 2024 | 2023 | 2022 |
Profit available for equity holders ($m) | 628 | 750 | 375 |
Basic weighted average number of ordinary shares (millions) | 161.2 | 169.0 | 181.0 |
Basic earnings per ordinary share (cents) | 389.6 | 443.8 | 207.2 |
Diluted earnings per ordinary share | |||
Profit available for equity holders ($m) | 628 | 750 | 375 |
Diluted weighted average number of ordinary shares (millions) | 163.0 | 170.0 | 182.0 |
Diluted earnings per ordinary share (cents) | 385.3 | 441.2 | 206.0 |
Basic and diluted share denominators are calculated as follows: | |||
2024 | 2023 | 2022 | |
millions | millions | millions | |
Weighted average number of ordinary shares in issue | 168.6 | 177.0 | 187.0 |
Weighted average number of treasury shares a | (7.4) | (8.0) | (6.0) |
Basic weighted average number of ordinary shares | 161.2 | 169.0 | 181.0 |
Dilutive potential ordinary shares | 1.8 | 1.0 | 1.0 |
Diluted weighted average number of ordinary shares | 163.0 | 170.0 | 182.0 |
Management | Other | |||||
Goodwill | Brands | Software | agreements | intangibles | Total | |
$m | $m | $m | $m | $m | $m | |
Cost | ||||||
At 1 January 2023 | 513 | 439 | 825 | 122 | 26 | 1,925 |
Additions | – | – | 52 | – | 1 | 53 |
Fully amortised assets written off | – | – | (52) | – | (3) | (55) |
Disposals | – | – | (1) | – | – | (1) |
Exchange and other adjustments | 3 | – | 1 | – | – | 4 |
At 31 December 2023 | 516 | 439 | 825 | 122 | 24 | 1,926 |
Additions | – | – | 48 | – | 1 | 49 |
Fully amortised assets written off | – | – | (49) | – | (1) | (50) |
Disposals | – | – | (4) | – | – | (4) |
Exchange and other adjustments | (5) | – | – | – | – | (5) |
At 31 December 2024 | 511 | 439 | 820 | 122 | 24 | 1,916 |
Amortisation and impairment | ||||||
At 1 January 2023 | (178) | – | (486) | (101) | (16) | (781) |
Provided | – | – | (18) | (1) | (2) | (21) |
System Fund expense | – | – | (76) | – | (1) | (77) |
Fully amortised assets written off | – | – | 52 | – | 3 | 55 |
Disposals | – | – | 1 | – | – | 1 |
Exchange and other adjustments | (2) | – | (1) | (1) | – | (4) |
At 31 December 2023 | (180) | – | (528) | (103) | (16) | (827) |
Provided | – | – | (17) | (1) | (1) | (19) |
System Fund expense | – | – | (77) | – | (1) | (78) |
Impairment charge | – | – | (2) | – | – | (2) |
System Fund impairment charge | – | – | (3) | – | – | (3) |
Fully amortised assets written off | – | – | 49 | – | 1 | 50 |
Disposals | – | – | 4 | – | – | 4 |
Exchange and other adjustments | – | – | 1 | – | – | 1 |
At 31 December 2024 | (180) | – | (573) | (104) | (17) | (874) |
Net book value | ||||||
At 31 December 2024 | 331 | 439 | 247 | 18 | 7 | 1,042 |
At 31 December 2023 | 336 | 439 | 297 | 19 | 8 | 1,099 |
At 1 January 2023 | 335 | 439 | 339 | 21 | 10 | 1,144 |
Analysed as: | |||||||
At 1 January | Exchange | At 31 December | Exchange | At 31 December | |||
2023 | adjustments | 2023 | adjustments | 2024 | Goodwill | Brands | |
$m | $m | $m | $m | $m | $m | $m | |
Americas (group of CGUs) | 419 | – | 419 | – | 419 | 132 | 287 |
EMEAA (group of CGUs) | 331 | 1 | 332 | (5) | 327 | 191 | 136 |
Greater China | 24 | – | 24 | – | 24 | 8 | 16 |
774 | 1 | 775 | (5) | 770 | 331 | 439 |
| 2024 | 2023 | |||
Terminal | Pre-tax | Terminal | Pre-tax | |
growth | discount | growth | discount | |
rate | rate | rate | rate | |
% | % | % | % | |
Americas | 2.1 | 11.6 | 1.6 | 13.0 |
EMEAA | 2.5 | 13.6 | 2.4 | 15.1 |
Greater China | 2.5 | 10.5 | 2.5 | 12.1 |
Fixtures, | |||
Land and | fittings and | ||
buildings | equipment | Total | |
$m | $m | $m | |
Cost | |||
At 1 January 2023 | 112 | 292 | 404 |
Additions | 1 | 20 | 21 |
Fully depreciated assets written off | – | (15) | (15) |
Disposals | (2) | (3) | (5) |
Exchange and other adjustments | – | 6 | 6 |
At 31 December 2023 | 111 | 300 | 411 |
Additions | – | 27 | 27 |
Fully depreciated assets written off | (3) | (27) | (30) |
Disposals | (8) | (8) | (16) |
Exchange and other adjustments | (1) | (4) | (5) |
At 31 December 2024 | 99 | 288 | 387 |
Depreciation and impairment | |||
At 1 January 2023 | (51) | (196) | (247) |
Provided | (6) | (18) | (24) |
System Fund expense | – | (4) | (4) |
Fully depreciated assets written off | – | 15 | 15 |
Disposals | 2 | 3 | 5 |
Exchange and other adjustments | 1 | (4) | (3) |
At 31 December 2023 | (54) | (204) | (258) |
Provided | (3) | (21) | (24) |
System Fund expense | – | (4) | (4) |
Impairment reversal | – | 3 | 3 |
Fully depreciated assets written off | 3 | 27 | 30 |
Disposals | – | 8 | 8 |
Exchange and other adjustments | 1 | 3 | 4 |
At 31 December 2024 | (53) | (188) | (241) |
Net book value | |||
At 31 December 2024 | 46 | 100 | 146 |
At 31 December 2023 | 57 | 96 | 153 |
At 1 January 2023 | 61 | 96 | 157 |
Land and | Investment | |||
buildings | property | Other | Total | |
$m | $m | $m | $m | |
Cost | ||||
At 1 January 2023 | 571 | 50 | 2 | 623 |
Additions and other re-measurements | 15 | – | 2 | 17 |
Transfers to investment property | (2) | 2 | – | – |
Terminations | (51) | – | (1) | (52) |
Exchange and other adjustments | 1 | – | – | 1 |
At 31 December 2023 | 534 | 52 | 3 | 589 |
Additions and other re-measurements | 28 | – | 5 | 33 |
Transfers to finance lease receivable | (13) | (14) | (4) | (31) |
Terminations | (11) | – | (1) | (12) |
Exchange and other adjustments | (5) | – | – | (5) |
At 31 December 2024 | 533 | 38 | 3 | 574 |
Depreciation and impairment | ||||
At 1 January 2023 | (294) | (47) | (2) | (343) |
Provided | (22) | – | – | (22) |
System Fund expense | (2) | – | – | (2) |
Transfers to investment property | 2 | (2) | – | – |
Terminations | 51 | – | 1 | 52 |
Exchange and other adjustments | (1) | – | – | (1) |
At 31 December 2023 | (266) | (49) | (1) | (316) |
Provided | (21) | – | (1) | (22) |
System Fund expense | 2 | – | – | 2 |
Transfers to finance lease receivable | 8 | 13 | – | 21 |
Terminations | 11 | – | 1 | 12 |
Exchange and other adjustments | 5 | – | – | 5 |
At 31 December 2024 | (261) | (36) | (1) | (298) |
Net book value | ||||
At 31 December 2024 | 272 | 2 | 2 | 276 |
At 31 December 2023 | 268 | 3 | 2 | 273 |
At 1 January 2023 | 277 | 3 | – | 280 |
2024 | 2023 | |
Currency | $m | $m |
US dollars | 357 | 357 |
Sterling | 31 | 32 |
Euros | 3 | 4 |
Other | 23 | 33 |
414 | 426 | |
Analysed as: | ||
Current | 26 | 30 |
Non-current | 388 | 396 |
414 | 426 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Depreciation of right-of-use assets | 22 | 22 | 25 |
System Fund depreciation of right-of-use assets | (2) | 2 | 3 |
Expense relating to variable lease payments | 77 | 62 | 47 |
Expense relating to short-term leases and low-value assets | 1 | 2 | 1 |
Income from operating subleases | (3) | (2) | (1) |
Recognised in operating profit | 95 | 86 | 75 |
Interest on lease liabilities | 30 | 29 | 29 |
Total recognised in the Group income statement | 125 | 115 | 104 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Operating activities | 108 | 92 | 72 |
Investing activities | (4) | – | (6) |
Financing activities | 46 | 28 | 36 |
Net cash paid | 150 | 120 | 102 |
2024 | 2023 | |
$m | $m | |
Cost | ||
At 1 January | 101 | 89 |
Additions | 6 | 3 |
Share of pro fits a | 10 | 13 |
System Fund share of losses | (2) | (3) |
Dividends and distributions | (7) | (1) |
At 31 December | 108 | 101 |
Impairment | ||
At 1 January | (53) | (53) |
Impairment charge | (4) | – |
At 31 December | (57) | (53) |
Net book value | 51 | 48 |
Analysed as: | ||
Barclay associate | 7 | 3 |
Other associates | 39 | 43 |
Joint ventures | 5 | 2 |
51 | 48 |
2024 | 2023 | |
$m | $m | |
Non-current assets | 449 | 462 |
Current assets | 112 | 86 |
Current liabilities | (21) | (23) |
Non-current liabilities | (236) | (256) |
Net assets | 304 | 269 |
Group’s share of reported net assets at 19.9% | 60 | 53 |
Adjustments to reflect impairment, capitalised costs and additional rights and obligations | ||
under the shareholder agreement | (11) | (8) |
Effect of specially allocated expenses (note 6) | (42) | (42) |
Carrying amount | 7 | 3 |
2024 | 2023 | |
$m | $m | |
Revenue | 130 | 131 |
Profit from continuing operations and total comprehensive income for the year | 15 | 15 |
Group’s share of pro fit for the year a | 4 | 3 |
2024 | 2023 | |
$m | $m | |
Equity securities | 97 | 102 |
Restricted funds: | ||
Ring-fenced amounts to satisfy insurance claims: | ||
Cash | 1 | 2 |
Money market funds | 10 | 14 |
Accounts pledged as security | 31 | 32 |
Other | 1 | 2 |
43 | 50 | |
Trade deposits and loans | 79 | 40 |
219 | 192 | |
Analysed as: | ||
Current | 7 | 7 |
Non-current | 212 | 185 |
219 | 192 |
| 2024 | 2023 | |||
Dividend | Dividend | |||
Fair value | income | Fair value | income | |
$m | $m | $m | $m | |
Investment in entity which owns: | ||||
InterContinental The Willard Washington DC | 27 | 1 | 27 | 1 |
InterContinental Grand Stanford Hong Kong | 36 | – | 37 | – |
2024 | 2023 | |
$m | $m | |
Current | ||
Trade receivables | 651 | 580 |
Other receivables | 41 | 68 |
Prepayments | 93 | 92 |
785 | 740 | |
Non-current | ||
Finance lease receivables | 12 | 6 |
Other receivables | 5 | 3 |
Prepayments | 18 | 4 |
35 | 13 |
| 2024 | 2023 | |||||
Credit loss | Credit loss | |||||
Gross | allowance | Net | Gross | allowance | Net | |
$m | $m | $m | $m | $m | $m | |
Not past due | 384 | – | 384 | 354 | (1) | 353 |
Past due 1 to 30 days | 90 | (4) | 86 | 88 | (5) | 83 |
Past due 31 to 90 days | 80 | (5) | 75 | 69 | (6) | 63 |
Past due 91 to 180 days | 53 | (8) | 45 | 51 | (8) | 43 |
Past due 181 to 360 days | 66 | (19) | 47 | 38 | (11) | 27 |
Past due more than 361 days | 98 | (84) | 14 | 86 | (75) | 11 |
771 | (120) | 651 | 686 | (106) | 580 | |
2024 | 2023 | |
Movement in the allowance for expected credit losses | $m | $m |
At 1 January | (106) | (117) |
Impairment (loss)/reversal | (16) | 1 |
System Fund impairment loss | (9) | – |
Amounts written off | 8 | 9 |
Exchange and other adjustments | 3 | 1 |
At 31 December | (120) | (106) |
2024 | 2023 | |
$m | $m | |
Cash at bank and in hand | 142 | 179 |
Short-term deposits | 411 | 632 |
Money market funds | 415 | 375 |
Repurchase agreements | 40 | 136 |
Cash and cash equivalents as recorded in the Group statement of financial position | 1,008 | 1,322 |
Bank overdrafts | (17) | (44) |
Cash and cash equivalents as recorded in the Group statement of cash flows | 991 | 1,278 |
2024 | 2023 | |
$m | $m | |
Countries with restrictions on repatriation | 2 | 30 |
Capital expenditure under lease agreements | 15 | 14 |
Other restrictions | 5 | 12 |
22 | 56 |
2024 | 2023 | |
$m | $m | |
Current | ||
Trade payables | 111 | 127 |
Other tax and social security payables | 61 | 47 |
Other payables | 116 | 135 |
Deferred purchase consideration | – | 13 |
Accruals | 362 | 389 |
650 | 711 | |
Non-current | ||
Other payables | 5 | 6 |
Contingent purchase consideration (note 24) | 73 | 69 |
78 | 75 |
Commercial | Self | |||
litigation and | insurance | Dilapidations | ||
disputes | reserves | and other | Total | |
$m | $m | $m | $m | |
At 31 December 2023 | 7 | 14 | 15 | 36 |
Provided | 10 | 4 | 4 | 18 |
Utilised | – | (9) | – | (9) |
Released | (3) | – | (2) | (5) |
Exchange and other adjustments | – | – | (1) | (1) |
At 31 December 2024 | 14 | 9 | 16 | 39 |
Analysed as: | ||||
Current | 13 | 3 | 6 | 22 |
Non-current | 1 | 6 | 10 | 17 |
14 | 9 | 16 | 39 |
2024 | 2023 | |
$m | $m | |
At 1 January | 37 | 32 |
Insurance expenses | 28 | 21 |
Claims and other amounts paid | (23) | (15) |
Impact of discounting and other changes | (3) | (1) |
At 31 December | 39 | 37 |
Analysed as: | ||
Current | 14 | 12 |
Non-current | 25 | 25 |
39 | 37 | |
Incurred but not reported claims a | 18 | 20 |
Reported but not settled claims | 21 | 17 |
39 | 37 |
2024 | 2023 | |
$m | $m | |
Revenue from insurance activities | 23 | 21 |
Insurance expenses (inclusive of overhead costs) | (29) | (23) |
Insurance result | (6) | (2) |
Discount | ||||
Maturity | at issue | 2024 | 2023 | |
date | % | $m | $m | |
Current | ||||
Bank overdrafts (note 17) | n/a | n/a | 17 | 44 |
€500m 1.625% bonds 2024 | 8 October 2024 | 0.437 | – | 555 |
£300m 3.75% bonds 2025 | 14 August 2025 | 0.986 | 381 | – |
398 | 599 | |||
Non-current | ||||
£300m 3.75% bonds 2025 | 14 August 2025 | 0.986 | – | 387 |
£350m 2.125% bonds 2026 | 24 August 2026 | 0.550 | 441 | 449 |
€500m 2.125% bonds 2027 | 15 May 2027 | 0.470 | 526 | 559 |
£400m 3.375% bonds 2028 | 8 October 2028 | 1.034 | 502 | 509 |
€600m 4.375% bonds 2029 | 28 November 2029 | 0.098 | 623 | 663 |
€750m 3.625% bonds 2031 | 27 September 2031 | 0.116 | 784 | – |
2,876 | 2,567 | |||
Total loans and other borrowings | 3,274 | 3,166 | ||
Denominated in the following currencies: | ||||
Sterling | 1,324 | 1,345 | ||
US dollars | 16 | 44 | ||
Euros | 1,933 | 1,777 | ||
Other | 1 | – | ||
3,274 | 3,166 |
2024 | 2023 | ||
$m | $m | ||
Cash and cash equivalents | 1,008 | 1,322 | |
Loans and other borrowings – current | (398) | (599) | |
– non-current | (2,876) | (2,567) | |
Lease liabilities | – current | (26) | (30) |
– non-current | (388) | (396) | |
Principal amounts payable on maturity of derivative financial instruments (note 23) | (102) | (2) | |
Net debt | (2,782) | (2,272) |
2024 | 2023 | |
Movement in net debt | $m | $m |
Net (decrease)/increase in cash and cash equivalents, net of overdrafts | (269) | 339 |
Add back financing cash flows in respect o f other components of net debt: | ||
Principal element of lease payments | 46 | 28 |
Issue of long-term bonds | (834) | (657) |
Repayment of long-term bonds | 547 | – |
Settlement of currency swaps | 45 | – |
(196) | (629) | |
Increase in net debt arising from cash flows | (465) | (290) |
Other movements: | ||
Lease liabilities | (36) | (25) |
Increase in accrued interest | (6) | (2) |
Exchange and other adjustments | (3) | (104) |
(45) | (131) | |
Increase in net debt | (510) | (421) |
Net debt at beginning of the year | (2,272) | (1,851) |
Net debt at end of the year | (2,782) | (2,272) |
At 1 | At 31 | ||||
January | Financing | Exchange | December | ||
2024 | cash flows | adjustments | Other a,b | 2024 | |
$m | $m | $m | $m | $m | |
Lease liabilities | 426 | (46) | (2) | 36 | 414 |
Bonds | 3,122 | 287 | (157) | 5 | 3,257 |
3,548 | 241 | (159) | 41 | 3,671 | |
Currency swaps | 20 | (45) | – | 103 | 78 |
Currency forwards | (15) | – | – | 11 | (4) |
3,553 | 196 | (159) | 155 | 3,745 |
At 1 | At 31 | ||||
January | Financing | Exchange | December | ||
2023 | cash flows | adjustments | Other a,b | 2023 | |
$m | $m | $m | $m | $m | |
Lease liabilities | 427 | (28) | 2 | 25 | 426 |
Bonds | 2,341 | 657 | 123 | 1 | 3,122 |
2,768 | 629 | 125 | 26 | 3,548 | |
Currency swaps | 4 | – | – | 16 | 20 |
Currency forwards | – | – | – | (15) | (15) |
2,772 | 629 | 125 | 27 | 3,553 |
2024 | 2023 | |
Derivatives | $m | $m |
Currency swaps | (78) | (20) |
Currency forwards | 4 | 15 |
(74) | (5) | |
Analysed as: | ||
Non-current assets | 4 | 20 |
Current liabilities | – | (25) |
Non-current liabilities | (78) | – |
(74) | (5) |
Date of | Hedge | Pay | Interest | Receive | Interest | |||
designation | type | leg | rate | leg | rate | Maturity | Risk | Hedged item |
November 2018 | Cash flow | £436m | 3.5% | €500m | 2.125% | May 2027 | Foreign exchange | €500m 2.125% bonds 2027 |
October 2020 | Cash flow | £454m | 2.7% | €500m | 1.625% | October 2024 | Foreign exchange | €500m 1.625% bonds 2024 |
November 2023 | Cash flow | $657m | 6.0% | €600m | 4.375% | November 2029 | Foreign exchange | €600m 4.375% bonds 2029 |
September 2024 | Cash flow | $834m | 4.9% | €750m | 3.625% | September 2031 | Foreign exchange | €750m 3.625% bonds 2031 |
October 2023 | Net | $425m | n/a | £344m | n/a | October 2028 | Spot foreign | Net assets of speci fied |
investment | exchange | subsidiaries with US dollar | ||||||
foreign currency |
2024 | 2023 | 2022 | ||
$m | $m | $m | ||
(Decrease)/increase in profit be fore tax | ||||
Sterling: US dollar exchange rate | $0.05 fall | (38) | (14) | (3) |
Euro: US dollar exchange rate | $0.05 fall | (7) | (3) | – |
US dollar interest rates | 1% increase | 4 | 2 | 4 |
Sterling interest rates | 1% increase | 3 | 9 | 4 |
Decrease/(increase) in net liabilities | ||||
Sterling: US dollar exchange rate | $0.05 fall | 3 | (12) | 27 |
Euro: US dollar exchange rate | $0.05 fall | 25 | 49 | 50 |
Sterling: euro exchange rate | €0.05 fall | 31 | 64 | 60 |
31 December | |
2024 a | |
Covenant test levels for RCF | |
Leverage | <4.0x |
Interest cover | >3.5x |
2024 | 2023 | 2022 | |
Covenant measures | |||
Covenant EBITDA ($m) | 1,195 | 1,086 | 896 |
Covenant net debt ($m) | 2,804 | 2,328 | 1,898 |
Covenant interest payable ($m) | 123 | 88 | 109 |
Leverage | 2.35 | 2.14 | 2.12 |
Interest cover | 9.72 | 12.34 | 8.22 |
Between | Between | ||||
Less than | 1 and 2 | 2 and 5 | More than | ||
1 year | years | years | 5 years | Total | |
31 December 2024 | $m | $m | $m | $m | $m |
Non-derivative financial liabilities: | |||||
Bank overdrafts | 17 | – | – | – | 17 |
Bonds | 482 | 531 | 1,859 | 837 | 3,709 |
Lease liabilities | 52 | 50 | 139 | 3,125 | 3,366 |
Trade and other payables (excluding deferred and contingent | |||||
purchase consideration) | 589 | 1 | 1 | 3 | 594 |
Contingent purchase consideration | – | 39 | 42 | – | 81 |
Financial guarantee contracts | 31 | – | – | – | 31 |
Derivative financial instruments: | |||||
Currency swaps hedging bonds inflows | (66) | (66) | (1,324) | (837) | (2,293) |
Currency swaps hedging bonds outflows | 101 | 100 | 1,457 | 916 | 2,574 |
Forward currency contract inflows | – | – | (431) | – | (431) |
Forward currency contract outflows | – | – | 425 | – | 425 |
Between | Between | ||||
Less than | 1 and 2 | 2 and 5 | More than | ||
1 year | years | years | 5 years | Total | |
31 December 2023 | $m | $m | $m | $m | $m |
Non-derivative financial liabilities: | |||||
Bank overdrafts | 44 | – | – | – | 44 |
Bonds | 644 | 464 | 1,681 | 694 | 3,483 |
Lease liabilities | 57 | 52 | 130 | 3,164 | 3,403 |
Trade and other payables (excluding deferred and contingent | |||||
purchase consideration) | 651 | 1 | 3 | 2 | 657 |
Deferred and contingent purchase consideration | 13 | – | 81 | – | 94 |
Financial guarantee contracts | 50 | – | – | – | 50 |
Derivative financial instruments: | |||||
Currency swaps hedging bonds inflows | (604) | (41) | (664) | (694) | (2,003) |
Currency swaps hedging bonds outflows | 653 | 59 | 704 | 696 | 2,112 |
Forward currency contract inflows | – | – | (438) | – | (438) |
Forward currency contract outflows | – | – | 425 | – | 425 |
BBB+ and | |||||||||
AAA | AA+ | AA | AA- | A+ | A | A- | below | Total | |
31 December 2024 | $m | $m | $m | $m | $m | $m | $m | $m | $m |
Short-term deposits | – | – | – | 41 | 107 | 249 | – | 14 | 411 |
Money market funds | 415 | – | – | – | – | – | – | – | 415 |
Repurchase agreement collateral | 26 | 9 | 2 | 3 | – | – | – | – | 40 |
BBB+ and | |||||||||
AAA | AA+ | AA | AA- | A+ | A | A- | below | Total | |
31 December 2023 | $m | $m | $m | $m | $m | $m | $m | $m | $m |
Short-term deposits | – | – | – | 129 | 147 | 258 | 77 | 21 | 632 |
Money market funds | 375 | – | – | – | – | – | – | – | 375 |
Repurchase agreement collateral | 110 | 6 | – | 20 | – | – | – | – | 136 |
| 2024 | 2023 | ||||||||
Not | Not | ||||||||
categorised | categorised | ||||||||
as a | as a | ||||||||
Hierarchy | Fair | Amortised | financial | Fair | Amortised | financial | |||
of fair value | value a | cost | instrument | Total | value a | cost | instrument | Total | |
measurement | $m | $m | $m | $m | $m | $m | $m | $m | |
Financial assets | |||||||||
Other financial assets | 1,3 b | 169 | 50 | – | 219 | 124 | 68 | – | 192 |
Cash and cash equivalents | 1 | 415 | 593 | – | 1,008 | 375 | 947 | – | 1,322 |
Derivative financial | |||||||||
instruments | 2 | 4 | – | – | 4 | 20 | – | – | 20 |
Deferred compensation | |||||||||
plan investments | 1 | 286 | – | – | 286 | 250 | – | – | 250 |
Trade and other | |||||||||
receivables | – | – | 697 | 123 | 820 | – | 651 | 102 | 753 |
Financial liabilities | |||||||||
Derivative financial | |||||||||
instruments | 2 | (78) | – | – | (78) | (25) | – | – | (25) |
Deferred compensation | |||||||||
plan liabilities | 1 | (286) | – | – | (286) | (250) | – | – | (250) |
Loans and other | |||||||||
borrowings | – | – | (3,274) | – | (3,274) | – | (3,166) | – | (3,166) |
Trade and other payables | 3 | (73) | (594) | (61) | (728) | (69) | (670) | (47) | (786) |
| 2024 | 2023 | ||||
Hierarchy of | Carrying | ||||
fair value | value | Fair value | Carrying value | Fair value | |
measurement | $m | $m | $m | $m | |
€500m 1.625% bonds 2024 | 1 | – | – | 555 | 545 |
£300m 3.75% bonds 2025 | 1 | 381 | 373 | 387 | 373 |
£350m 2.125% bonds 2026 | 1 | 441 | 418 | 449 | 416 |
€500m 2.125% bonds 2027 | 1 | 526 | 513 | 559 | 535 |
£400m 3.375% bonds 2028 | 1 | 502 | 471 | 509 | 476 |
€600m 4.375% bonds 2029 | 1 | 623 | 658 | 663 | 689 |
€750m 3.625% bonds 2031 | 1 | 784 | 786 | – | – |
Other | Contingent | ||
financial | Other | purchase | |
assets | payables | consideration | |
$m | $m | $m | |
At 1 January 2023 | 103 | (18) | (65) |
Valuation losses recognised in other comprehensive income | (2) | – | – |
Additions | 8 | – | – |
Unrealised changes in fair value a | – | 18 | (4) |
Exchange and other adjustments | 1 | – | – |
At 31 December 2023 | 110 | – | (69) |
Additions | 20 | – | – |
Unrealised changes in fair value | – | – | (4) |
Repayments and disposals | (4) | – | – |
At 31 December 2024 | 126 | – | (73) |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Profit for the year | 628 | 750 | 376 |
Adjustments for: | |||
Net financial expenses | 140 | 52 | 96 |
Fair value losses/(gains) on contingent purchase consideration | 4 | 4 | (8) |
Income tax charge | 269 | 260 | 164 |
Operating profit adjustments: | |||
Impairment loss/(reversal) on financial assets | 10 | (1) | 5 |
Other net impairment (reversals)/charges | – | – | (5) |
Other operating exceptional items | 12 | (28) | 100 |
Depreciation and amortisation | 65 | 67 | 68 |
87 | 38 | 168 | |
Contract assets deduction in revenue | 43 | 37 | 32 |
Share-based payments cost | 44 | 36 | 30 |
Share of pro fits o f associates and joint ventures (before exceptional items) | (10) | (13) | (1) |
77 | 60 | 61 | |
System Fund adjustments: | |||
Depreciation and amortisation | 80 | 83 | 86 |
Impairment loss on financial assets | 9 | – | 7 |
Other impairment charges | 3 | – | – |
Share-based payments cost | 23 | 20 | 16 |
Share of losses of associates | 2 | 3 | 1 |
117 | 106 | 110 | |
Working capital and other adjustments: | |||
Increase in deferred revenue | 214 | 123 | 108 |
Increase in trade and other receivables | (106) | (70) | (132) |
(Decrease)/increase in trade and other payables | (45) | 31 | 121 |
Other adjustments | (7) | (5) | 4 |
56 | 79 | 101 | |
Cash flows relating to exceptional items | 8 | (29) | (43) |
Contract acquisition costs, net of repayments | (237) | (101) | (64) |
Total adjustments | 521 | 469 | 585 |
Cash flow from operations | 1,149 | 1,219 | 961 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
At 1 January | 66 | 66 | 92 |
Recognised in profit or loss | |||
Interest expense | 5 | 3 | 2 |
5 | 3 | 2 | |
Recognised in other comprehensive income | |||
Actuarial (gain)/loss arising from changes in: | |||
Demographic assumptions | – | (1) | (1) |
Financial assumptions | (3) | 2 | (22) |
Experience adjustments | (1) | 1 | 2 |
Re-measurement (gain)/loss | (4) | 2 | (21) |
Exchange and other adjustments | 7 | – | (2) |
3 | 2 | (23) | |
Other | |||
Group contributions | (6) | (5) | (5) |
(6) | (5) | (5) | |
At 31 December | 68 | 66 | 66 |
Comprising: | |||
UK plan | 17 | 19 | 18 |
US plans | 31 | 34 | 35 |
US post-retirement plan | 13 | 13 | 13 |
Other post-employment benefit plans | 7 | – | – |
68 | 66 | 66 |
2024 | 2023 | 2022 | |
% | % | % | |
UK plan only: | |||
Pension increases | 3.2 | 3.1 | 3.2 |
Inflation rate | 3.2 | 3.1 | 3.2 |
Discount rate: | |||
UK plan | 5.6 | 4.8 | 5.0 |
US plans | 5.3 | 4.7 | 4.9 |
US post-retirement plan | 5.3 | 4.7 | 4.9 |
US healthcare cost trend rate assumed for the next year: | |||
Pre-65 (ultimate rate reached in 2035) | 8.6 | 7.8 | 6.9 |
Post-65 (ultimate rate reached in 2035) | 9.7 | 8.6 | 7.3 |
Ultimate rate that the cost rate trends to | 4.5 | 4.5 | 4.5 |
| UK | US | ||||||
2024 | 2023 | 2022 | 2024 | 2023 | 2022 | ||
years | years | years | years | years | years | ||
Current pensioners at 65 a | – male | 23 | 23 | 24 | 22 | 22 | 22 |
– female | 25 | 25 | 26 | 23 | 23 | 23 | |
Future pensioners at 65 b | – male | 23 | 23 | 25 | 23 | 23 | 23 |
– female | 25 | 25 | 27 | 25 | 25 | 25 | |
2024 | 2023 | ||
$m | $m | ||
Discount rate | 1% decrease | 5 | 6 |
1% increase | (5) | (6) | |
Inflation rate | 0.25% decrease | (1) | (1) |
0.25% increase | – | 1 | |
Mortality rate | One-year increase | 2 | 3 |
Healthcare costs trend rate | 1% decrease | (1) | (1) |
1% increase | 1 | 1 |
2024 | 2023 | |
$m | $m | |
Within one year | 5 | 5 |
Between one and five years | 20 | 21 |
More than five years | 81 | 86 |
106 | 112 |
2024 | 2023 | |
years | years | |
UK plan | 12.0 | 13.0 |
US plans | 7.1 | 7.5 |
US post-retirement plan | 7.4 | 8.0 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Equity-settled | |||
Operating profit be fore System Fund, reimbursables and exceptional items | 37 | 31 | 28 |
System Fund | 23 | 20 | 16 |
60 | 51 | 44 | |
Cash-settled | |||
Operating profit be fore System Fund, reimbursables and exceptional items | 7 | 5 | 2 |
67 | 56 | 46 |
| APP | LTIP | |||||
| Monte Carlo Simulation, Binomial | ||||||
| Binomial valuation model | and Finnerty valuation models | |||||
Option pricing models and assumptions | 2024 | 2023 | 2022 | 2024 | 2023 | 2022 |
Weighted average share price (pence) | 8,481.8 | 5,571.7 | 5,018.3 | 7,940.0 | 5,318.0 | 4,875.0 |
Expected dividend yield | 2.12% | 2.52% to 2.77% | 2.29% to 2.67% | |||
Risk-free interest rate | 4.20% | 3.85% | 1.29% | |||
Volatility a | 26% | 29% to 30% | 35% to 45% | |||
Term (years) | 2.2 | 2.3 | 1.7 | 3.0 | 3.0 | 3.0 |
APP/DAP | LTIP/DAP | ||
Deferred shares/ | Performance-related | Restricted stock | |
Number of share awards (thousands) | one-off awards | awards/LTI | units |
Outstanding at 1 January 2022 | 348 | 872 | 1,350 |
Granted | 236 | 323 | 706 |
Vested | (254) | (23) | (391) |
Lapsed or cancelled | (9) | (239) | (90) |
Outstanding at 31 December 2022 | 321 | 933 | 1,575 |
Granted | 214 | 329 | 683 |
Vested | (186) | (180) | (533) |
Lapsed or cancelled | (17) | (246) | (63) |
Outstanding at 31 December 2023 | 332 | 836 | 1,662 |
Granted | 104 | 279 | 495 |
Vested | (44) | (136) | (402) |
Lapsed or cancelled | (6) | (148) | (106) |
Outstanding at 31 December 2024 | 386 | 831 | 1,649 |
Fair value of awards granted during the year (cents) | |||
2024 | 10,837.6 | 5,812.6 | 10,302.3 |
2023 | 6,926.4 | 3,169.7 | 6,351.0 |
2022 | 6,180.2 | 3,770.0 | 5,656.4 |
Weighted average remaining contract life (years) | |||
At 31 December 2024 | 0.9 | 1.1 | 1.1 |
At 31 December 2023 | 1.5 | 1.3 | 1.3 |
At 31 December 2022 | 1.0 | 1.1 | 1.2 |
Equity | ||||
Number | Nominal | Share | share | |
of shares | value | premium | capital | |
Allotted, called up and fully paid | millions | $m | $m | $m |
At 1 January 2022 (ordinary shares of 20 340 ⁄ 399 p each) | 187 | 53 | 101 | 154 |
Repurchased and cancelled under share repurchase programme | (4) | (1) | – | (1) |
Exchange adjustments | – | (6) | (10) | (16) |
At 31 December 2022 (ordinary shares of 20 340 ⁄ 399 p each) | 183 | 46 | 91 | 137 |
Repurchased and cancelled under share repurchase programme | (11) | (3) | – | (3) |
Exchange adjustments | – | 3 | 4 | 7 |
At 31 December 2023 (ordinary shares of 20 340 ⁄ 399 p each) | 172 | 46 | 95 | 141 |
Repurchased and cancelled under share repurchase programme | (7) | (2) | – | (2) |
Exchange adjustments | – | (1) | (1) | (2) |
At 31 December 2024 (ordinary shares of 20 340 ⁄ 399 p each) | 165 | 43 | 94 | 137 |
Number of | |||
shares | Carrying value | Market value | |
millions | $m | $m | |
31 December 2024 | 1.2 | 63.0 | 144.9 |
31 December 2023 | 0.8 | 35.0 | 73.6 |
31 December 2022 | 1.1 | 37.0 | 62.8 |
Number of | Nominal | |
shares | value | |
millions | $m | |
At 1 January 2022 | 3.7 | 1.0 |
Transferred to employee share trusts | (0.7) | (0.2) |
Repurchased under share repurchase programme | 4.5 | 1.1 |
At 31 December 2022 | 7.5 | 1.9 |
Transferred to employee share trusts | (0.5) | (0.1) |
Exchange adjustments | – | 0.1 |
At 31 December 2023 | 7.0 | 1.9 |
Transferred to employee share trusts | (0.8) | (0.2) |
Exchange adjustments | – | (0.1) |
At 31 December 2024 | 6.2 | 1.6 |
Cash flow | Cost of | ||
hedge | hedging | ||
reserve | reserve | Total | |
$m | $m | $m | |
At 1 January 2022 | 16 | (11) | 5 |
Costs of hedging deferred and recognised in other comprehensive income | – | 3 | 3 |
Change in fair value of currency swaps recognised in other comprehensive income | 33 | – | 33 |
Reclassified from other comprehensive income to pro fit or loss – included in | |||
financial expenses | (43) | – | (43) |
Deferred tax | 2 | – | 2 |
At 31 December 2022 | 8 | (8) | – |
Change in fair value of currency swaps recognised in other comprehensive income | (30) | – | (30) |
Reclassified from other comprehensive income to pro fit or loss – included in | |||
financial expenses | 28 | – | 28 |
At 31 December 2023 | 6 | (8) | (2) |
Costs of hedging deferred and recognised in other comprehensive income | – | (11) | (11) |
Change in fair value of currency swaps recognised in other comprehensive income | (113) | – | (113) |
Reclassified from other comprehensive income to pro fit or loss – included in | |||
financial expenses | 165 | – | 165 |
Deferred tax | (11) | – | (11) |
At 31 December 2024 | 47 | (19) | 28 |
2024 | 2023 | 2022 | |
Total compensation | $m | $m | $m |
Short-term employment benefits | 20.1 | 18.6 | 18.7 |
Contributions to defined contribution pension plans | 0.4 | 0.5 | 0.5 |
Equity compensation benefits a | 16.4 | 15.8 | 13.4 |
36.9 | 34.9 | 32.6 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Fee revenue | 12 | 11 | 9 |
Amounts receivable (net) | 41 | 19 | 10 |
Amounts payable | – | (10) | – |
2024 | 2023 | 2022 | |
$m | $m | $m | |
System Fund revenues | 1,611 | 1,564 | 1,217 |
Reimbursable revenues | 1,000 | 896 | 832 |
System Fund and reimbursable revenues | 2,611 | 2,460 | 2,049 |
System Fund expenses | (1,694) | (1,545) | (1,322) |
Reimbursable expenses | (1,000) | (896) | (832) |
System Fund and reimbursable expenses | (2,694) | (2,441) | (2,154) |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Loyalty programme revenues, net of the cost of point redemptions | 355 | 379 | 228 |
Marketing, reservation and other hotel fees | 1,256 | 1,185 | 989 |
2024 | 2023 | 2022 | |
$m | $m | $m | |
Marketing | 520 | 498 | 408 |
Staff costs | 436 | 399 | 341 |
Depreciation and amortisation | 80 | 83 | 86 |
Impairment loss on trade receivables (note 16) | 9 | – | 7 |
Other net impairment charges (note 11) | 3 | – | – |